Pre-surgery risk reduction for pancreatic surgery
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study helps people going for planned pancreatic cancer surgery (with or without chemo beforehand) by focusing on controllable risk factors before the operation. The goal is to improve safety and outcomes after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your doctors are planning an elective (planned) pancreatic operation for curative treatment (with or without chemo before surgery).
- Your surgery is scheduled at one of the Dutch Pancreatic Cancer Group participating centers.
- Your planned surgery date is more than 2 weeks away (not an emergency/urgent operation).
- You are not having an acute pancreatic resection (scheduled within the next 2 weeks).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a program of exercise, nutrition, and psychological support before major cancer surgery can help you recover faster and have fewer complications. It is designed for people who are at higher risk of surgical complications due to other health conditions.
This study looks at how the surgeon's cutting edges (margins) and the way the tumor sits in the pancreas affect outcomes for people having surgery for pancreatic cancer. By joining, you'll help researchers learn how to improve surgery and planning for future patients.
This trial tests a pre-surgery exercise program (prehab) for people with pancreatic cancer who plan to have chemotherapy first. The goal is to see if getting stronger before surgery helps with recovery.
This study compares two approaches to preventing blood clots around the time of pancreatic surgery. It may help lower the risk of dangerous clotting events after surgery, especially for people who are high risk.
This trial compares two approaches for patients with pancreatic or periampullary cancer that can be surgically removed: getting chemotherapy before surgery (neoadjuvant therapy) versus surgery first. It aims to find out which sequence leads to better outcomes.
This trial studies an “implementation program” to help patients with locally advanced pancreatic cancer get ready for the next steps after chemotherapy. It may help improve care planning and outcomes for people whose cancer has not grown after initial treatment.
Hear when a new Prehabilitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.